These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 10380824)

  • 21. Therapeutic advantages of Auger electron- over beta-emitting radiometals or radioiodine when conjugated to internalizing antibodies.
    Behr TM; Béhé M; Löhr M; Sgouros G; Angerstein C; Wehrmann E; Nebendahl K; Becker W
    Eur J Nucl Med; 2000 Jul; 27(7):753-65. PubMed ID: 10952487
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of radiolabeling monoclonal antibodies with a residualizing iodine radiolabel on the accretion of radioisotope in tumors.
    Stein R; Goldenberg DM; Thorpe SR; Basu A; Mattes MJ
    Cancer Res; 1995 Jul; 55(14):3132-9. PubMed ID: 7606734
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Iodination of monoclonal IgG antibodies at a sub-stoichiometric level: immunoreactivity changes related to the site of iodine incorporation.
    Matzku S; Kirchgessner H; Nissen M
    Int J Rad Appl Instrum B; 1987; 14(5):451-7. PubMed ID: 3117738
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Monoclonal antibodies labeled with rhenium-186 using the MAG3 chelate: relationship between the number of chelated groups and biodistribution characteristics.
    van Gog FB; Visser GW; Klok R; van der Schors R; Snow GB; van Dongen GA
    J Nucl Med; 1996 Feb; 37(2):352-62. PubMed ID: 8667076
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-linear energy transfer (LET) alpha versus low-LET beta emitters in radioimmunotherapy of solid tumors: therapeutic efficacy and dose-limiting toxicity of 213Bi- versus 90Y-labeled CO17-1A Fab' fragments in a human colonic cancer model.
    Behr TM; Béhé M; Stabin MG; Wehrmann E; Apostolidis C; Molinet R; Strutz F; Fayyazi A; Wieland E; Gratz S; Koch L; Goldenberg DM; Becker W
    Cancer Res; 1999 Jun; 59(11):2635-43. PubMed ID: 10363986
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vivo biodistribution of a humanized anti-Lewis Y monoclonal antibody (hu3S193) in MCF-7 xenografted BALB/c nude mice.
    Clarke K; Lee FT; Brechbiel MW; Smyth FE; Old LJ; Scott AM
    Cancer Res; 2000 Sep; 60(17):4804-11. PubMed ID: 10987290
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Immunoscintigraphy of anti-type IV collagenase monoclonal antibody in nude mice bearing human lung cancer xenograft].
    Dai Y; Jia B; Wang F; Du J; Shang BY; Zhen YS
    Ai Zheng; 2003 Dec; 22(12):1243-8. PubMed ID: 14693044
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Radiolocalization of xenografted human lung cancer with monoclonal antibody 8 in nude mice.
    Endo K; Kamma H; Ogata T
    Cancer Res; 1987 Oct; 47(20):5427-32. PubMed ID: 3652045
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Radioimmunoscintigraphy using an anti-prostate monoclonal antibody (E4): a dosimetric evaluation.
    Rydh A; Riklund Ahlström K; Widmark A; Johansson L; Nilsson S; Bergh A; Damber JE; Stigbrand T; Hietala SO
    Urol Res; 2001 Jun; 29(3):216-20. PubMed ID: 11482450
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of multiple bolus and continuous injections of 131I-labeled CC49 for therapy in a colon cancer xenograft model.
    Buchsbaum DJ; Khazaeli MB; Mayo MS; Roberson PL
    Clin Cancer Res; 1999 Oct; 5(10 Suppl):3153s-3159s. PubMed ID: 10541357
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 99mTc-labeled divalent and tetravalent CC49 single-chain Fv's: novel imaging agents for rapid in vivo localization of human colon carcinoma.
    Goel A; Baranowska-Kortylewicz J; Hinrichs SH; Wisecarver J; Pavlinkova G; Augustine S; Colcher D; Booth BJ; Batra SK
    J Nucl Med; 2001 Oct; 42(10):1519-27. PubMed ID: 11585867
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro and in vivo targeting properties of iodine-123- or iodine-131-labeled monoclonal antibody 14C5 in a non-small cell lung cancer and colon carcinoma model.
    Burvenich I; Schoonooghe S; Cornelissen B; Blanckaert P; Coene E; Cuvelier C; Mertens N; Slegers G
    Clin Cancer Res; 2005 Oct; 11(20):7288-96. PubMed ID: 16243799
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Radiolabeled fragments of monoclonal antibodies against carcinoembryonic antigen for localization of human colon carcinoma grafted into nude mice.
    Buchegger F; Haskell CM; Schreyer M; Scazziga BR; Randin S; Carrel S; Mach JP
    J Exp Med; 1983 Aug; 158(2):413-27. PubMed ID: 6886623
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapeutic efficacy and dose-limiting toxicity of Auger-electron vs. beta emitters in radioimmunotherapy with internalizing antibodies: evaluation of 125I- vs. 131I-labeled CO17-1A in a human colorectal cancer model.
    Behr TM; Sgouros G; Vougiokas V; Memtsoudis S; Gratz S; Schmidberger H; Blumenthal RD; Goldenberg DM; Becker W
    Int J Cancer; 1998 May; 76(5):738-48. PubMed ID: 9610734
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Studies of the interactions between the anticytokeratin 8 monoclonal antibody TS1, its antigen and its anti-idiotypic antibody alphaTS1.
    Erlandsson A; Holm P; Ullén A; Stigbrand T; Sundström BE
    J Mol Recognit; 2003; 16(3):157-63. PubMed ID: 12833571
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeting human cancer xenografts with monoclonal antibodies labeled using radioiodinated, diethylenetriaminepentaacetic acid-appended peptides.
    Stein R; Govindan SV; Mattes MJ; Shih LB; Griffiths GL; Hansen HJ; Goldenberg DM
    Clin Cancer Res; 1999 Oct; 5(10 Suppl):3079s-3087s. PubMed ID: 10541347
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunoreactivity of monoclonal anti-melanoma antibodies in relation to the amount of radioactive iodine substituted to the antibody molecule.
    Matzku S; Kirchgessner H; Dippold WG; Brüggen J
    Eur J Nucl Med; 1985; 11(6-7):260-4. PubMed ID: 4076233
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combined low dose radio- and radioimmunotherapy of experimental HeLa Hep 2 tumours.
    Eriksson D; Joniani HM; Sheikholvaezin A; Löfroth PO; Johansson L; Riklund Ahlström K; Stigbrand T
    Eur J Nucl Med Mol Imaging; 2003 Jun; 30(6):895-906. PubMed ID: 12721768
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biokinetics of a F(ab')3 iodine-131 labeled antigen binding construct (Mab 35) directed against CEA in patients with colorectal carcinoma.
    Storto G; Buchegger F; Waibel R; Kuenzi G; Offord RE; Schubiger PA; Gillet M; Delaloye AB
    Cancer Biother Radiopharm; 2001 Oct; 16(5):371-9. PubMed ID: 11776754
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Technetium-99m-labeled antibodies. Stability compared to 125I labeled antibodies.
    Gooden CS; Snook DE; Epenetos AA
    Cell Biophys; 1993; 22(1-3):49-59. PubMed ID: 7889542
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.